Magnesium Citrate

Introduction Overview

Generic Name

magnesium citrate

Brand Name

Citrate of Magnesia
Citroma Cherry
Citroma Lemon
ColonX
OneLAX Magnesium Citrate
Citroma
Natrol Mood + Stress
Colace Gummies

Dosage Form

oral capsule (100 mg; 125 mg; 133.3 mg)
oral liquid (1.745 g/30 mL)
oral tablet (100 mg)
oral tablet, chewable (66.66 mg)

Drug Class

Laxatives

Pharmacokinetics

Absorption:
Magnesium citrate is well absorbed from the gastrointestinal tract, primarily in the small intestine. The citrate component facilitates the solubilization and bioavailability of magnesium ions, enhancing absorption compared to other magnesium salts. Absorption rates may vary depending on the dosage form, concurrent food intake, and gastrointestinal transit time. Magnesium citrate exhibits moderate oral bioavailability, with approximately 30-50% of the administered dose absorbed under normal conditions. Co-administration with food can improve magnesium uptake while mitigating gastrointestinal side effects such as diarrhea and cramping. Conversely, rapid intestinal transit, as seen in diarrhea or laxative use, can decrease absorption efficiency.

Distribution:
Once absorbed, magnesium is distributed predominantly in intracellular compartments, including bone, muscle, and soft tissues. Serum magnesium constitutes only about 1% of total body magnesium, tightly regulated within a normal range of 1.7 to 2.5 mg/dL. Magnesium ions circulate mostly in ionized form, with a small fraction bound to proteins (approximately 20-30%). Magnesium homeostasis is maintained through a delicate balance among intestinal absorption, renal excretion, and bone storage. The volume of distribution approximates total body water distribution since magnesium is mainly intracellular. Clinical factors like acid-base balance and serum albumin levels can influence magnesium plasma binding and distribution.

Metabolism:
Magnesium citrate itself is not metabolized enzymatically but dissociates into magnesium ions and citrate anions upon exposure to gastric acid. The citrate moiety is metabolized primarily in the Krebs cycle within tissues, contributing to energy production pathways. Citrate metabolism impacts acid-base homeostasis by generating bicarbonate, which may counteract acidosis. Magnesium ions act as cofactors for numerous enzymatic reactions, including ATP synthesis and nucleic acid metabolism, but do not undergo metabolic transformations themselves.

Elimination:
Elimination of magnesium occurs mainly via the kidneys, where approximately 70-80% of filtered magnesium is reabsorbed in the thick ascending loop of Henle and distal tubules. Magnesium renal excretion closely correlates with serum levels and is modulated by factors such as volume status, parathyroid hormone, and serum calcium levels. Magnesium citrate’s laxative effect accelerates intestinal motility, promoting bowel evacuation before complete absorption, with unabsorbed magnesium excreted fecally. Renal impairment can predispose to magnesium accumulation and toxicity if dosage is not appropriately adjusted. The half-life of magnesium in plasma varies but is generally around 1-3 hours, reflecting rapid renal clearance in individuals with normal kidney function.

Dosage Forms

Available Dosage Forms:
Magnesium citrate is available in multiple oral formulations designed for flexibility in clinical use and patient preference. The dosage forms include:
- Oral capsules in strengths of 100 mg, 125 mg, and 133.3 mg
- Oral liquid suspension with concentration of 1.745 g per 30 mL
- Oral tablets of 100 mg
- Oral chewable tablets of 66.66 mg
These formulations allow for tailored dosing regimens, especially important for patients across different age groups or those requiring titration of magnesium intake.

Dosages for Adults and Adolescents:
For treatment of occasional constipation, the usual adult dose of magnesium citrate oral liquid is typically 240 mL taken orally one time. The laxative effect usually occurs within 30 minutes to 6 hours post-administration. Dose titration is guided by clinical response to avoid prolonged diarrhea or electrolyte imbalance. Pediatric dosing varies with age and weight:
- Children under 6 years: 0.5 mL/kg orally, with a maximum of 200 mL dose; dosage may be repeated every 4 to 6 hours until stools are clear.
- Children 6 to 12 years: 100 to 150 mL orally one time.
These dosing recommendations emphasize careful administration and monitoring to mitigate adverse gastrointestinal effects.

Specific Patient Populations:
In patients with renal impairment, dosing adjustments or avoidance may be necessary due to risks of magnesium retention and toxicity. Similarly, patients on low-magnesium or low-sodium diets should consult healthcare providers before usage. Pregnant and breastfeeding individuals should only use magnesium citrate under medical guidance. Use in elderly patients necessitates close observation due to altered renal clearance and potential electrolyte disturbances. Administration should be accompanied by adequate hydration, and dosing should be individualized considering concurrent medications and comorbidities. Children with underlying gastrointestinal illnesses or electrolyte disorders also require cautious dosing and monitoring.

Mechanism Of Action

Magnesium citrate exerts its pharmacologic effects primarily through the osmotic activity of magnesium ions within the gastrointestinal lumen. Upon ingestion, magnesium citrate dissociates into magnesium ions and citrate anions; the magnesium ions are poorly absorbed in high concentrations, resulting in osmotic retention of water in the intestinal tract. This increased luminal water content softens stool consistency and stimulates peristalsis, facilitating bowel evacuation. This laxative effect is beneficial for occasional constipation and pre-procedural bowel cleansing.

At the molecular level, magnesium ions modulate smooth muscle contractility in the intestinal wall by influencing calcium signaling pathways, reducing muscle tone alterations and enhancing motility. Additionally, magnesium acts as a natural calcium antagonist, helping to relax skeletal and smooth muscles, thereby contributing to alleviation of muscle cramps and spasms sometimes associated with constipation.

Citrate ions derived from magnesium citrate participate in systemic acid-base regulation once absorbed, metabolized into bicarbonate ions, which help buffer systemic pH. This contributes to the overall homeostasis in metabolic conditions, although this effect is secondary to its laxative properties.

Comparatively, magnesium citrate offers a more rapid onset of action and predictable absorption profile than other magnesium salts such as magnesium oxide. Clinical studies have demonstrated its efficacy in inducing bowel movements within 30 minutes to 6 hours, contrasting with bulk-forming laxatives that require longer duration for therapeutic effects. The combined osmotic and motility effects make magnesium citrate a valuable agent in clinical and over-the-counter management of constipation with a well-established safety profile.

Pharmacological Actions

Acts as an osmotic laxative by increasing water content in the intestines to soften stool
Stimulates intestinal peristalsis facilitating bowel movement
Modulates smooth muscle contractility by regulating calcium influx
Provides supplemental magnesium to correct magnesium deficiency
Contributes to systemic acid-base balance through citrate metabolism
Acts as a calcium antagonist to relax gastrointestinal smooth muscles
Induces rapid bowel evacuation used for colon cleansing pre-procedures
Exerts minimal systemic absorption leading to localized gastrointestinal effects
Improves gastrointestinal motility without direct stimulation of nerve endings
Supports muscle function by replenishing cellular magnesium stores
Facilitates electrolyte balance in patients with magnesium depletion
Laxative effects typically onset within 30 minutes to 6 hours post-dose
Compatible with various oral dosage forms increasing patient compliance
Less likely to cause dependence compared to stimulant laxatives
May enhance absorption of other orally administered nutrients by improving bowel transit

Therapeutic Or Clinical Uses

Treatment of occasional constipation in adults and children
Bowel preparation to cleanse colon prior to diagnostic procedures such as colonoscopy
Supplementation to maintain adequate magnesium levels in deficiency states
Adjunct therapy in conditions requiring magnesium replenishment
Management of hypomagnesemia when oral administration is feasible
Relief of symptoms associated with slow intestinal transit
Support for digestive health by promoting regular bowel movements
Temporary treatment for gastrointestinal motility disorders
Aid in softening stool to prevent strain during defecation
Off-label use in certain muscle cramp conditions related to magnesium deficiency
Part of multimodal approach in metabolic acidosis through citrate metabolism
May be used in patients intolerant to bulk-forming or stimulant laxatives
Useful in pediatric constipation under appropriate dosing and monitoring
Facilitates rapid evacuation to reduce risk of fecal impaction
Supports management of constipation related to opioid therapy

Side Or Adverse Effects

Diarrhea or loose stools due to osmotic water retention
Abdominal cramping and stomach discomfort
Nausea and occasional vomiting
Dizziness possibly related to fluid and electrolyte shifts
Increased sweating secondary to gastrointestinal irritation
Flushing, warmth, and redness indicative of hypersensitivity
Muscle weakness associated with electrolyte imbalance
Pain during bowel movements or rectal bleeding as signs of irritation
Difficult or painful urination potentially linked to magnesium effects
Light-headedness and risk of syncope from dehydration
Slow heartbeat or shallow breathing in severe magnesium toxicity
Risk of allergic reactions including hives, swelling of face, lips, or throat
Electrolyte disturbances in patients with renal impairment
Potential dehydration with excessive use or overdose
Bloating and increased intestinal gas

Precautions

Use cautiously in patients with kidney disease due to impaired magnesium clearance
Avoid if there is a sudden change in bowel habits lasting longer than 2 weeks without medical evaluation
Seek medical advice if abdominal pain, nausea, or vomiting is present prior to use
Consult a physician if on low-magnesium or low-sodium diets before starting
Avoid excessive or prolonged use to prevent dependence or electrolyte imbalance
Use with caution during pregnancy and breastfeeding under medical supervision
Ensure adequate hydration during administration to prevent dehydration
Monitor for signs of electrolyte disturbances especially in elderly or debilitated patients
Avoid concurrent use with other oral medications within 2 hours to prevent absorption interference
Not recommended in patients with bowel obstruction or undiagnosed abdominal pain
Careful administration in pediatric populations with weight-based dosing
Discontinue and seek medical advice in case of allergic symptoms or lack of bowel movement after 6 hours
Store medication at room temperature away from moisture and heat
Inform healthcare providers of all concomitant medications to avoid interactions
Avoid use in patients with severe cardiovascular disease without medical consultation

Warnings

Follow all directions on the label and packaging strictly; use only as directed
Risk of serious adverse effects including delayed bowel movement and severe diarrhea
Stop use immediately and contact doctor if no bowel movement within 6 hours
Be alert for signs of significant dehydration or electrolyte disturbances
Risk of allergic reactions, including anaphylaxis, necessitating emergency care
Not for use in individuals with renal insufficiency without medical supervision
Avoid use if experiencing stomach pain, nausea, or vomiting to prevent complications
Avoid combining with other laxatives unless directed by a healthcare professional
May cause electrolyte imbalance if overused or misused
Use caution in patients with cardiac conduction abnormalities due to magnesium effects
Not recommended for long-term use to avoid laxative dependence
Avoid use in patients with intestinal obstruction or perforation
Exposure to heat and moisture can degrade the product; store properly
Seek immediate help if experiencing weakness, slow heartbeat, or breathing difficulties
Use in pregnancy only when the potential benefits justify the potential risks

Contraindication

Known hypersensitivity or allergy to magnesium citrate or any formulation components
Patients with bowel obstruction or undiagnosed abdominal pain
Renal failure or severe kidney impairment where magnesium excretion is compromised
Signs of acute surgical abdomen requiring surgical intervention
Severe dehydration or electrolyte imbalance prior to treatment
Use contraindicated in patients with coma or severely altered consciousness
Concurrent use contraindicated with other magnesium-containing products without medical oversight
History of magnesium toxicity or hypermagnesemia
Use contraindicated in conditions with impaired gastrointestinal motility such as ileus
Patients with risk of fecal impaction or suspected mechanical obstruction
Contraindicated during certain stages of pregnancy unless medically approved
Children under the age of 2 years unless specifically prescribed
Patients with significant cardiovascular disorders sensitive to magnesium effects
Contraindicated in patients with systemic disorders causing electrolyte abnormalities
Use contraindicated in presence of any unexplained rectal bleeding

Drug Interactions

Concurrent use with other laxatives may potentiate effects and increase risk of diarrhea or dehydration
Magnesium citrate may reduce the absorption of certain oral medications if taken simultaneously
Avoid taking other oral drugs within 2 hours before or after magnesium citrate administration
Potential interaction with antibiotics such as tetracyclines and fluoroquinolones reducing their efficacy
May affect absorption of bisphosphonates, thyroid hormones, and certain antiretrovirals
Interactions with diuretics may alter magnesium and electrolyte balance
Concomitant use with neuromuscular blockers can potentiate muscle relaxation effects
Magnesium citrate may antagonize calcium channel blockers in rare cases
Agents causing bradycardia or hypotension may have enhanced effects when combined
Avoid concurrent use with digoxin unless monitored carefully
Possible additive effects with other magnesium-containing supplements leading to toxicity
May affect serum levels of other electrolytes such as potassium and calcium
Caution with concurrent use of antacids containing aluminum or calcium
Interactions with certain herbal products that affect gastrointestinal motility
Potential interference with oral contraceptives absorption if stool transit time is significantly altered

Preparations Of The Drug

Magnesium citrate oral capsules in 100 mg, 125 mg, and 133.3 mg strengths
Magnesium citrate oral liquid suspension with concentration of 1.745 g per 30 mL
Magnesium citrate oral tablets containing 100 mg dosages
Chewable oral tablets containing 66.66 mg magnesium citrate
Over-the-counter preparations available in flavored liquids for palatability
Prescribed formulations designed for bowel cleansing prior to medical procedures
Combination products with other laxatives or stool softeners in some brand variants
Flavor variations including cherry, lemon, and unflavored formulations
Gummy formulations combined with other supplements like Colace Gummies
Liquid preparations come with measuring devices for accurate dosing
Available in various packaging sizes to accommodate single-dose or multiple-dose regimens
Some preparations include citrate buffers to maintain pH and drug stability
Formulations intended for pediatric dosing require precise measurement and monitoring
Stability-enhanced formulations to prolong shelf-life under recommended storage conditions
Non-prescription versions accessible for occasional use with clear dosing instructions